GENNADY CHERNYAK: Open Payments
NPI 1487698072 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,477 in 97 payments from 12 companies in 2025. Trend: 2023 $1,691 · 2024 $2,135 · 2025 $2,477
Food & beverage: $2,470Education: $7
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $452 |
| Galderma Laboratories, L.P. | 7 | $384 |
| UCB, Inc. | 14 | $343 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $318 |
| Novartis Pharmaceuticals Corporation | 15 | $269 |
| Regeneron Healthcare Solutions, Inc. | 5 | $200 |
| Amgen Inc. | 3 | $194 |
| Janssen Biotech, Inc. | 13 | $176 |
| LEO Pharma Inc. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
Products named: NEMLUVIO, SKYRIZI, Bimzelx, DUPIXENT, OTEZLA, TREMFYA, Rhapsido, Leqselvi.
Industry payments across IN — which companies pay providers there.
